GV
GPN VACCINES, INC.
SEC filingBiotechnology · Wilmington, DE
Amount raised$3.5Msold at filing
Total offering$10M$6.5M still open
Investors in the raise63count reported to the SEC
FiledJan 28, 2026first sale Dec 24, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Timothy HirstExecutive Officer, Director
James SelkirkExecutive Officer
Executive officers, directors and promoters as listed on the Form D.